Slaughter and May has promoted corporate lawyer Charlton Tse to partner at its Hong Kong office.

Tse specialises in mergers and acquisitions and corporate finance, and is expected to help develop the firm’s corporate and investment banking client relationships in Hong Kong and China.

“[Charlton] is a highly accomplished M&A and corporate finance lawyer with experience both in private practice and as an in-house counsel,” said Peter Brien, partner at Slaughter and May Hong Kong, in a statement. “His strong connections will allow him to play an important part in developing our corporate and investment banking client relationships across the region.”

The promotion means Slaughter and May’s Hong Kong office now has 13 partners and 45 legal staff based in Hong Kong and Beijing.

 

Related Articles

Deals

CC, Slaughters advise as HK-listed SciClone goes private for $1.13 bln

by Hu Yangxiaoxiao 胡阳潇潇 |

Clifford Chance has advised the Hong Kong-listed SciClone Pharmaceuticals on an offer to take it private by healthcare-focused private equity firm GL Capital, with Slaughter and May acting for the buyer’s financial adviser, Capital Corporation Hong Kong Securities (CICC).

Deals

Slaughters, Skadden guide $1.8 bln acquisition of Coke Philippines

by Mari Iwata |

Slaughter and May, Villaraza & Angangco, Skadden, Arps, Slate, Meagher & Flom, SyCip Salazar Hernandez & Gatmaitan have advised the buyers on a $1.8 billion acquisition of Coca-Cola Beverages Philippines (CCBPI) from Coca-Cola.

Deals

Goodwin, MoFo, Slaughters guide $478 mln bio-pharma acquisition

by Nimitt Dixit |

U.S. law firm Morrison Foerster has advised Japan’s Kyowa Kirin on its $477.6 million acquisition of British biopharmaceutical company Orchard Therapeutics, which was represented by Goodwin Procter. Slaughter & May was Orchard’s UK legal advisor.